OGT Licenses Array IP to Two More Japanese Companies | GenomeWeb
NEW YORK (GenomeWeb News) – Two more Japanese companies have licensed Oxford Gene Technology’s oligonucleotide microarray patents to sell arrays, OGT said today.
 
Bio Matrix Research, a bio venture company launched by Tokyo University of Science, will develop and commercialize products and microarrays to be marketed in Japan, the company said.
 
Filgen will conduct a microarray service in Japan using licensed microarrays.
 
The licenses will remain valid for the patents’ lifetime.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.